Biohaven Ltd.
Biohaven Ltd. (BHVN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bhvn · stock forecast · 25 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 25 Wall Street analysts in the past 3 months
Buy
25 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$23.00
Consensus
$17.60
+58.6% upside
Low
$10.00
Median: $18 · Last Close: $11.10
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$17.60
58.6% upside
High Target
$23
107.2%
Low Target
$10
-9.9%
Current Price
$11.10
as of today
Based on analyst price targets, the BHVN stock price prediction for the next 12 months ranges from $10 to $23. The consensus BHVN price forecast of $17.60 implies 58.6% upside from the current price of $11.10.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $11.66 | ↑ 5.00% |
1-day model range: $11.54–$11.77. Peak: $11.77 (+5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BHVN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2026-05-13 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-05-05 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-02 | Citigroup | Maintains | Buy→Buy |
| 2026-03-11 | TD Cowen | Maintains | Buy→Buy |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2026-03-03 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-01-21 | RBC Capital | Upgrade ↑ | Sector Perform→Outperform |
| 2026-01-06 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2025-12-26 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Biohaven Ltd. (BHVN) stock. Of the recent 135 rating actions, 1 were upgrades and 13 were downgrades. 25 analysts currently cover BHVN.
Analyst Recommendation Trends
BHVN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 97.3% YoY
Revenue Next Year
$17M
↑ 591.0% YoY
EPS This Year
$-3.00
EPS Next Year
$-2.44
↓ 18.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast BHVN EPS of $-3.00 for the current fiscal year, based on estimates from 11 analysts. The BHVN revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BHVN stock forecast is supported by two independent data sources: analyst consensus ratings from 25 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BHVN price target is $17.60 (+58.6% upside), with an analyst consensus of Buy.
The BHVN short-term stock prediction for tomorrow is $11.66 (+5.00%).
Biohaven Ltd. trades on NYSE under the ticker BHVN. The BHVN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 72% of covering analysts.
Frequently asked questions
BHVN forecast · 8 questionsAccording to 25 Wall Street analysts, the average 12-month BHVN price target is $17.60, with a high forecast of $23.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies +58.6% potential upside from the current price of $11.10.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.